Stammdaten
Unternehmen
| Name | Nuvalent, Inc. |
|---|---|
| Ticker | NUVL |
| CIK | 0001861560 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Nuvalent, Inc. |
Status
| Zuletzt geprüft | 2026-03-20 22:27:03.694325 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-13 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -1,703 | 99.71 | -169,806.13 | -9,8% | |
| 2026-03-13 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -804 | 97.89 | -78,703.56 | -4,5% | |
| 2026-03-13 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -2,597 | 98.83 | -256,661.51 | -14,8% | |
| 2026-03-13 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -1,703 | 99.71 | -169,806.13 | -9,8% | |
| 2026-03-13 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -804 | 97.89 | -78,703.56 | -4,5% | |
| 2026-03-13 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -2,597 | 98.83 | -256,661.51 | -14,8% | |
| 2026-03-12 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -24,189 | 97.79 | -2,365,442.31 | -136,3% | |
| 2026-03-12 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -306 | 99.12 | -30,330.72 | -1,7% | |
| 2026-03-12 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -5,505 | 98.44 | -541,912.20 | -31,2% | |
| 2026-03-12 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -24,189 | 97.79 | -2,365,442.31 | -136,3% | |
| 2026-03-12 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -306 | 99.12 | -30,330.72 | -1,7% | |
| 2026-03-12 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -5,505 | 98.44 | -541,912.20 | -31,2% | |
| 2026-01-06 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -189 | 98.40 | -18,597.60 | -1,1% | |
| 2026-01-06 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -1,106 | 96.75 | -107,005.50 | -6,2% | |
| 2026-01-06 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -225 | 98.40 | -22,140.00 | -1,3% | |
| 2026-01-06 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -1,635 | 97.33 | -159,134.55 | -9,2% | |
| 2026-01-06 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -1,321 | 96.75 | -127,806.75 | -7,4% | |
| 2026-01-06 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -1,369 | 97.33 | -133,244.77 | -7,7% | |
| 2026-01-05 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -513 | 96.06 | -49,278.78 | -2,8% | |
| 2026-01-05 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -1,929 | 97.96 | -188,964.84 | -10,9% | |
| 2026-01-05 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -317 | 98.52 | -31,230.84 | -1,8% | |
| 2026-01-05 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -1,119 | 96.85 | -108,375.15 | -6,2% | |
| 2026-01-05 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -871 | 96.06 | -83,668.26 | -4,8% | |
| 2026-01-05 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -660 | 96.85 | -63,921.00 | -3,7% | |
| 2026-01-05 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -1,137 | 97.96 | -111,380.52 | -6,4% | |
| 2026-01-05 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -186 | 98.52 | -18,324.72 | -1,1% | |
| 2025-12-08 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -100 | 111.32 | -11,132.00 | -0,6% | |
| 2025-12-08 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -6,984 | 110.31 | -770,405.04 | -44,4% | |
| 2025-11-24 | Flynn James E | Director, 10% Owner | Open Market Sale | -371,287 | 95.45 | -35,437,487.72 | -2041,8% | |
| 2025-11-24 | Flynn James E | Director, 10% Owner | Open Market Sale | -371,287 | 95.45 | -35,437,487.72 | -2041,8% | |
| 2025-11-24 | Flynn James E | Director, 10% Owner | Open Market Sale | -371,287 | 95.45 | -35,437,487.72 | -2041,8% | |
| 2025-11-18 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -509 | 104.54 | -53,210.86 | -3,1% | |
| 2025-11-18 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -220 | 103.61 | -22,794.20 | -1,3% | |
| 2025-11-17 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -4,496 | 100.58 | -452,207.68 | -26,1% | |
| 2025-11-17 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -3,194 | 102.13 | -326,203.22 | -18,8% | |
| 2025-11-17 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -5,055 | 103.27 | -522,029.85 | -30,1% | |
| 2025-11-17 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -380 | 103.68 | -39,398.40 | -2,3% | |
| 2025-11-17 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -3,609 | 93.80 | -338,524.20 | -19,5% | |
| 2025-11-17 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -3,266 | 95.12 | -310,661.92 | -17,9% | |
| 2025-10-15 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -14,205 | 90.04 | -1,279,018.20 | -73,7% | |
| 2025-10-15 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -1,683 | 85.57 | -144,014.31 | -8,3% | |
| 2025-10-14 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -400 | 87.39 | -34,956.00 | -2,0% | |
| 2025-10-14 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -866 | 86.11 | -74,571.26 | -4,3% | |
| 2025-10-14 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -1,167 | 84.98 | -99,171.66 | -5,7% | |
| 2025-10-14 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -5,820 | 86.63 | -504,186.60 | -29,1% | |
| 2025-10-14 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -1,700 | 87.67 | -149,039.00 | -8,6% | |
| 2025-10-14 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -200 | 88.90 | -17,780.00 | -1,0% | |
| 2025-10-14 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -12,280 | 85.75 | -1,053,010.00 | -60,7% | |
| 2025-10-13 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -7,637 | 89.81 | -685,878.97 | -39,5% | |
| 2025-10-13 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -1,596 | 89.22 | -142,395.12 | -8,2% | |
| 2025-10-13 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -12,266 | 88.73 | -1,088,362.18 | -62,7% | |
| 2025-10-13 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -6,138 | 87.90 | -539,530.20 | -31,1% | |
| 2025-10-01 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -19,030 | 85.43 | -1,625,732.90 | -93,7% | |
| 2025-10-01 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -970 | 86.37 | -83,778.90 | -4,8% | |
| 2025-09-30 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -20,000 | 85.06 | -1,701,200.00 | -98,0% | |
| 2025-09-29 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -7,588 | 85.01 | -645,055.88 | -37,2% | |
| 2025-09-10 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -3,725 | 78.83 | -293,641.75 | -16,9% | |
| 2025-08-25 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -1,348 | 73.96 | -99,698.08 | -5,7% | |
| 2025-08-25 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -109 | 75.63 | -8,243.67 | -0,5% | |
| 2025-08-25 | Noci Darlene | Officer, Chief Development Officer | Open Market Sale | -2,543 | 74.93 | -190,546.99 | -11,0% | |
| 2025-08-15 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -20,035 | 75.22 | -1,507,032.70 | -86,8% | |
| 2025-08-15 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -100 | 76.90 | -7,690.00 | -0,4% | |
| 2025-08-15 | Porter James Richard | Director, Officer, President and CEO | Open Market Sale | -6,865 | 75.98 | -521,602.70 | -30,1% | |
| 2025-08-07 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -5,500 | 74.85 | -411,675.00 | -23,7% | |
| 2025-08-07 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -5,500 | 74.85 | -411,675.00 | -23,7% | |
| 2025-07-16 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -14,700 | 85.10 | -1,250,970.00 | -72,1% | |
| 2025-07-15 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -54 | 85.48 | -4,615.92 | -0,3% | |
| 2025-07-15 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -2,484 | 82.67 | -205,352.28 | -11,8% | |
| 2025-07-15 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -1,888 | 83.87 | -158,346.56 | -9,1% | |
| 2025-07-15 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -874 | 84.91 | -74,211.34 | -4,3% | |
| 2025-07-10 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -5,260 | 79.94 | -420,484.40 | -24,2% | |
| 2025-07-10 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -240 | 80.92 | -19,420.80 | -1,1% | |
| 2025-07-09 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -200 | 81.90 | -16,380.00 | -0,9% | |
| 2025-07-09 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -1,945 | 81.08 | -157,700.60 | -9,1% | |
| 2025-06-27 | Balcom Alexandra | Officer, Chief Financial Officer | Open Market Sale | -20,000 | 80.02 | -1,600,400.00 | -92,2% | |
| 2025-06-27 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -2,170 | 79.92 | -173,426.40 | -10,0% | |
| 2025-06-25 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -8,630 | 79.87 | -689,278.10 | -39,7% | |
| 2025-06-06 | Pelish Henry E. | Officer, Chief Scientific Officer | Open Market Sale | -200 | 79.82 | -15,964.00 | -0,9% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.